Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
Biernacki T, Sandi D, Füvesi J, Fricska-Nagy Z, Kincses TZ, Ács P, Rózsa C, Dobos E, Cseh B, Horváth L, Nagy Z, Csányi A, Kovács K, Csépány T, Vécsei L, Bencsik K; on the behalf of the study investigators. Biernacki T, et al. Among authors: rozsa c. PLoS One. 2022 Apr 22;17(4):e0267346. doi: 10.1371/journal.pone.0267346. eCollection 2022. PLoS One. 2022. PMID: 35452476 Free PMC article.
Epidemiology of familial multiple sclerosis in Hungary.
Fricska-Nagy Z, Bencsik K, Rajda C, Füvesi J, Honti V, Csépány T, Dobos E, Mátyás K, Rózsa C, Komoly S, Vécsei L. Fricska-Nagy Z, et al. Among authors: rozsa c. Mult Scler. 2007 Mar;13(2):260-1. doi: 10.1177/1352458506070767. Epub 2007 Jan 29. Mult Scler. 2007. PMID: 17439894
APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis.
Losonczi E, Bencsik K, Fricska Nagy Z, Honti V, Szalczer E, Rajda C, Illés Z, Mátyás K, Rózsa C, Csépány T, Füvesi J, Vécsei L. Losonczi E, et al. Among authors: rozsa c. Swiss Med Wkly. 2010 Nov 26;140:w13119. doi: 10.4414/smw.2010.13119. eCollection 2010. Swiss Med Wkly. 2010. PMID: 21110240 Free article.
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
Kalincik T, Horakova D, Spelman T, Jokubaitis V, Trojano M, Lugaresi A, Izquierdo G, Rozsa C, Grammond P, Alroughani R, Duquette P, Girard M, Pucci E, Lechner-Scott J, Slee M, Fernandez-Bolanos R, Grand'Maison F, Hupperts R, Verheul F, Hodgkinson S, Oreja-Guevara C, Spitaleri D, Barnett M, Terzi M, Bergamaschi R, McCombe P, Sanchez-Menoyo J, Simo M, Csepany T, Rum G, Boz C, Havrdova E, Butzkueven H; MSBase Study Group. Kalincik T, et al. Among authors: rozsa c. Ann Neurol. 2015 Mar;77(3):425-35. doi: 10.1002/ana.24339. Epub 2015 Jan 17. Ann Neurol. 2015. PMID: 25546031 Clinical Trial.
The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
Fricska-Nagy Z, Füvesi J, Rózsa C, Komoly S, Jakab G, Csépány T, Jobbágy Z, Lencsés G, Vécsei L, Bencsik K. Fricska-Nagy Z, et al. Among authors: rozsa c. Mult Scler Relat Disord. 2016 May;7:26-32. doi: 10.1016/j.msard.2016.02.006. Epub 2016 Feb 12. Mult Scler Relat Disord. 2016. PMID: 27237753
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Kalincik T, Brown JWL, Robertson N, Willis M, Scolding N, Rice CM, Wilkins A, Pearson O, Ziemssen T, Hutchinson M, McGuigan C, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Alroughani R, Pucci E, Sola P, Hupperts R, Lechner-Scott J, Terzi M, Van Pesch V, Rozsa C, Grand'Maison F, Boz C, Granella F, Slee M, Spitaleri D, Olascoaga J, Bergamaschi R, Verheul F, Vucic S, McCombe P, Hodgkinson S, Sanchez-Menoyo JL, Ampapa R, Simo M, Csepany T, Ramo C, Cristiano E, Barnett M, Butzkueven H, Coles A; MSBase Study Group. Kalincik T, et al. Among authors: rozsa c. Lancet Neurol. 2017 Apr;16(4):271-281. doi: 10.1016/S1474-4422(17)30007-8. Epub 2017 Feb 11. Lancet Neurol. 2017. PMID: 28209331 Free article.
Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
Sandi D, Biernacki T, Szekeres D, Füvesi J, Kincses ZT, Rózsa C, Mátyás K, Kása K, Matolcsi J, Zboznovits D, Burány Z, Langane É, Vécsei L, Bencsik K. Sandi D, et al. Among authors: rozsa c. Mult Scler Relat Disord. 2017 Oct;17:57-62. doi: 10.1016/j.msard.2017.06.017. Epub 2017 Jul 1. Mult Scler Relat Disord. 2017. PMID: 29055476
91 results